MEXICO CITY — Mexico will conduct late-stage clinical trials for COVID-19 vaccines in development by Johnson & Johnson and two Chinese companies, the foreign ministry said on Tuesday.
Large-scale, phase three human testing for the J&J unit Janssen Pharmaceuticals’s candidate could start in the second half of September, the company has previously said.
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
Mexico will also help test candidates for Chinese companies Cansino Biologics Inc and Walvax Biotechnology Co Ltd, the ministry said in a presentation at a news conference.
View link »